Figure 4
Figure 4. CD4+SPT are more sensitive to IL-7 therapy than CD4+PERI. (A) STAT5 phosphorylation in CD4+PERI vs CD4+SPT exposed to varying concentrations of rhIL-7. Results are representative of 3 independent experiments. (B) Quantification of bcl2 RNA expression on CD4+PERI and CD4+ SPT exposed to varying IL-7 concentrations for 6 hours. Data show 1 mouse representative of 3 independent experiments. (C) Bcl-2 expression in CD4+PERI vs CD4+SPT exposed to varying concentrations of rhIL-7. (D) Representative flow cytometric analysis of IL-7Rα (CD127) and CD132 (common γC chain) evaluated on fresh CD4+CD8− thymocytes (CD4+SPT) and peripheral CD4+ T cells. Data are representative of 5 mice pooled from 3 independent experiments.

CD4+SPT are more sensitive to IL-7 therapy than CD4+PERI. (A) STAT5 phosphorylation in CD4+PERI vs CD4+SPT exposed to varying concentrations of rhIL-7. Results are representative of 3 independent experiments. (B) Quantification of bcl2 RNA expression on CD4+PERI and CD4+SPT exposed to varying IL-7 concentrations for 6 hours. Data show 1 mouse representative of 3 independent experiments. (C) Bcl-2 expression in CD4+PERI vs CD4+SPT exposed to varying concentrations of rhIL-7. (D) Representative flow cytometric analysis of IL-7Rα (CD127) and CD132 (common γC chain) evaluated on fresh CD4+CD8 thymocytes (CD4+SPT) and peripheral CD4+ T cells. Data are representative of 5 mice pooled from 3 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal